第一作者:
Ralf,Weiskirchen
第一单位:
Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, Germany.
作者:
关键词
GLP‐1 receptor agonistcancer, chronic kidney disease, drug adverse effectshealth‐care costsmajor adverse cardiovascular eventsmental healthmetabolic dysfunction‐associated steatotic liver diseasemetabolic functionobesitypersonalised medicinepharmacoeconomicsquality of lifetype 2 diabetesweight loss
DOI
10.1111/bph.70003
PMID
39947645
发布时间
2025-02-13
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文